A team of scientists and entrepreneurs is trying to build a company around a dataset from a large multi-omics clinical study funded by Genome Canada.
Vice President Joe Biden has announced the creation of a Genomic Data Commons.
The initiative, launched last year by Quest and the French National Institute of Health and Medical Research, has reclassified 375 variants of unknown significance so far.
Recently established biomedical informatics divisions at the hospital support projects like Bench-to-Bassinet and the Longitudinal Pediatric Data Resource.
Under the terms of the agreement, the partners will share de-identified genomic and clinical data as well as explore new opportunities for collaboration.
The FDA, journals, and even payors are encouraging labs to deposit variant data in public databases, but collaboration is needed to resolve interpretation discrepancies.
Ranomics is building a business around providing functional data on variants of unknown significance, starting with BRCA1 mutations.
Inova is using Translational's platform to evaluate data from MediMap, a new test that evaluates pharmacogenetics markers in seven genes in newborns.
The international group has released a second tier of public data so researchers and genetic counselors can see information on specific variants across databases.
Fujitsu has developed a method of aggregating genomic information that makes it easier and quicker to query large numbers of variants for GWAS.
23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.
By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.